M X13 (Pramipexole Dihydrochloride 0.75 mg)
Pill with imprint M X13 is Gray, Round and has been identified as Pramipexole Dihydrochloride 0.75 mg. It is supplied by Mylan Pharmaceuticals Inc..
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M X13
Pramipexole Dihydrochloride
- Imprint
- M X13
- Strength
- 0.75 mg
- Color
- Gray
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-1713
- Inactive Ingredients
-
silicon dioxide, hydroxypropyl cellulose (type h), magnesium stearate, mannitol, corn starch, FD&C Yellow No. 6, FD&C Blue No. 2
Note: Inactive ingredients may vary.
Related Images for "M X13"
More about pramipexole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 183 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
Other brands: Mirapex, Mirapex ER
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
